Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle

Journal of Virology

Volumn 82, Issue 20, 2008, Pages 10262-10270

  Bourne, Christina ^a,e   Lee, Sejin ^b   Venkataiah, Bollu ^b   Lee, Angela ^a   Korba, Brent ^c   Finn, M G ^b   Zlotnick, Adam ^a,d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY   (United States)

^e OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; CAPSID PROTEIN; LAMIVUDINE; PYRIMIDINE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN HEPG2; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THERMODYNAMICS; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CULTURE; VIRUS INHIBITION; VIRUS REPLICATION; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION;

HEPATITIS B VIRUS; MIRIDAE;

BINDING SITES; CAPSID; HEPATITIS B VIRUS; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; PYRIMIDINES; THERMODYNAMICS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 53749103127     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01360-08     Document Type: Article

References (36)

1. Angus, P., R. Vaughan, S. Xiong, H. Yang, W. Delaney, C. Gibbs, C. Brosgart, D. Colledge, R. Edwards, A. Ayres, A. Bartholomeusz, and S. Locarnini. 2003. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125:292-297.
2. Bottcher, B., S. A. Wynne, and R. A. Crowther. 1997. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386:88-91.
3. Bourne, C., M. G. Finn, and A. Zlotnick. 2006. Global structural changes in hepatitis B capsids induced by the assembly effector HAP1. J. Virol. 80:11055-11061.
4. Brazil, M. 2005. HIV-1. Viral assembly inhibitors on the horizon. Nat. Rev. Drug Discov. 4:716-717.
5. Ceres, P., and A. Zlotnick. 2002. Weak protein-protein interactions are sufficient to drive assembly of hepatitis B virus capsids. Biochemistry 41:11525-11531.
6. Conway, J. F., N. Cheng, A. Zlotnick, P. T. Wingfield, S. J. Stahl, and A. C. Steven. 1997. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature 386:91-94.
7. Deres, K., and H. Rubsamen-Waigmann. 1999. Development of resistance and perspectives for future therapies against hepatitis B infections: lessons to be learned from HIV. Infection 27(Suppl. 2):S45-S51.
8. Deres, K., C. H. Schroder, A. Paessens, S. Goldmann, H. J. Hacker, O. Weber, T. Kramer, U. Niewohner, U. Pleiss, J. Stoltefuss, E. Graef, D. Koletzki, R. N. Masantschek, A. Reimann, R. Jaeger, R. Gross, B. Beckermann, K. H. Schlemmer, D. Haebich, and H. Rubsamen-Waigmann. 2003. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299:893-896.
9. Endres, D., and A. Zlotnick. 2002. Model-based analysis of assembly kinetics for virus capsids or other spherical polymers. Biophys. J. 83:1217-1230.
10. Ganem, D., and R. J. Schneider. 2001. Hepadnaviridae: the viruses and their replication, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
11. Hacker, H. J., K. Deres, M. Mildenberger, and C. H. Schroder. 2003. Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion. Biochem. Pharmacol. 66:2273-2279.
12. Iyer, R. P., Y. Jin, A. Roland, J. D. Morrey, S. Mounir, and B. Korba. 2004. Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents. Antimicrob. Agents Chemother. 48:2199-2205.
13. Korba, B. E., and J. L. Gerin. 1992. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. Antivir. Res. 19:55-70.
14. Lewis-Hall, F. C. 2007. Re: Important information regarding BARACLUDE (entecavir) in patients co-infected with HIV and HBV. Food and Drug Administration MedWatch Program. Food and Drug Administration, Washington, DC. http://www.fda.gov/MedWatch/safety/2007/Baraclude_DHCP_02-2007.pdf.
15. Prevelige, P. E. J. 1998. Inhibiting virus-capsid assembly by altering the polymerisation pathway. Trends Biotechnol. 16:61-65.
16. Reddy, V. S., P. Natarajan, B. Okerberg, K. Li, K. V. Damodaran, R. T. Morton, C. L. Brooks III, and J. E. Johnson. 2001. Virus Particle Explorer (VIPER), a website for virus capsid structures and their computational analyses. J. Virol. 75:11943-11947.
17. Seeger, C., and W. S. Mason. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64:51-68.
18. Smith, T. J., M. J. Kremer, M. Luo, G. Vriend, E. Arnold, G. Kamer, M. G. Rossmann, M. A. McKinlay, G. D. Diana, and M. J. Otto. 1986. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286-1293.
19. Stoltefuss, J., S. Goldmann, T. Krämer, K.-H. Schlemmer, U. Niewöhner, A. Paessens, S. Lottmann, K. Deres, and O. Weber. October 1999. New dihydropyrimidine derivatives and their corresponding mesomers useful as antiviral agents. WO patent 19999954326.
20. Stolting, J., J. Stoltefuss, S. Goldmann, T. Kramer, K.-H. Schlemmer, U. Niewohner, A. Paessens, E. Graef, S. Lottmann, K. Deres, and O. Weber. May 2000. Preparation of 4-aryl-2-pyridinyl-1,4-dihydropyrimidine-5-carboxylates for treatment of hepatitis B infection. WO patent; 2000 058302.
21. Stray, S. J., C. R. Bourne, S. Punna, W. G. Lewis, M. G. Finn, and A. Zlotnick. 2005. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc. Natl. Acad. Sci. USA 102:8138-8143.
22. Stray, S. J., J. M. Johnson, B. G. Kopek, and A. Zlotnick. 2006. An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly. Nat. Biotechnol. 24:358-362.
23. Stray, S. J., and A. Zlotnick. 2006. BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly. J. Mol. Recognit. 19:542-548.
24. Tennant, B. C., B. H. Baldwin, L. A. Graham, M. A. Ascenzi, W. E. Hornbuckle, P. H. Rowland, I. A. Tochkov, A. E. Yeager, H. N. Erb, J. M. Colacino, C. Lopez, J. A. Engelhardt, R. R. Bowsher, F. C. Richardson, W. Lewis, P. J. Cote, B. E. Korba, and J. L. Gerin. 1998. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection. Hepatology 28:179-191.
25. Torresi, J., L. Earnest-Silveira, G. Deliyannis, K. Edgtton, H. Zhuang, S. A. Locarnini, J. Fyfe, T. Sozzi, and D. C. Jackson. 2002. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293:305-313.
26. Tsang, S. K., P. Danthi, M. Chow, and J. M. Hogle. 2000. Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects. J. Mol. Biol. 296:335-340.
27. Tsang, S. K., B. M. McDermott, V. R. Racaniello, and J. M. Hogle. 2001. Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst. J. Virol. 75:4984-4989.
28. Wynne, S. A., R. A. Crowther, and A. G. Leslie. 1999. The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3:771-780.
29. Zandi, R., P. van der Schoot, D. Reguera, W. Kegel, and H. Reiss. 2006. Classical nucleation theory of virus capsids. Biophys. J. 90:1939-1948.
30. Zhang, W., H. J. Hacker, M. Tokus, T. Bock, and C. H. Schroder. 2003. Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy. J. Med. Virol. 71:24-30.
31. Zlotnick, A. 2003. Are weak protein-protein interactions the general rule in capsid assembly? Virology 315:269-274.
32. Zlotnick, A. 1994. To build a virus capsid. An equilibrium model of the self assembly of polyhedral protein complexes. J. Mol. Biol. 241:59-67.
33. Zlotnick, A., P. Ceres, S. Singh, and J. M. Johnson. 2002. A small molecule inhibits and misdirects assembly of hepatitis B virus capsids. J. Virol. 76:4848-4854.
34. Zlotnick, A., J. M. Johnson, P. W. Wingfield, S. J. Stahl, and D. Endres. 1999. A theoretical model successfully identifies features of hepatitis B virus capsid assembly. Biochemistry 38:14644-14652.
35. Zlotnick, A., A. Lee, C. R. Bourne, J. M. Johnson, P. L. Domanico, and S. J. Stray. 2007. In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions). Nat. Protoc. 2:490-498.
36. Zlotnick, A., and S. J. Stray. 2003. How does your virus grow? Understanding and interfering with virus assembly. Trends Biotechnol. 21:536-542.